Global Inhaled Nitric Oxide Market Report and Forecast 2024-2032

Global Inhaled Nitric Oxide Market Outlook

The global inhaled nitric oxide market stood at a value of around USD 800.00 million in 2023. The market is further expected to grow at a CAGR of 8.1% in the forecast period of 2024-2032 to attain USD 1,612.69 million by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Growing Product Utilisation in Neonatal Respiratory Treatment to Bolster the Growth of the Inhaled Nitric Oxide Industry

Based on application, the neonatal respiratory treatment segment accounts for a significant share in the market and is anticipated to witness a considerable growth in the forecast period. The growth of this segment can be attributed to the rising cases of pulmonary hypertension, neonatal hypoxic respiratory failure, and new born respiratory distress syndrome, among others. In this regard, nitric oxide dilates and relaxes the muscle tension and dilates blood vessels, which leads to proper absorption of oxygen in the body. Additionally, inhaled nitric oxide also reduces the need for extracorporeal membrane oxygenation in infants suffering from persistent pulmonary hypertension. Over the forecast period, the growing cases of breathing problems among geriatrics are likely to augment the growth of the inhaled nitric oxide industry.

The Asia Pacific to Account for a Significant Share of the Inhaled Nitric Oxide Industry

The inhaled nitric oxide industry in the Asia Pacific is driven by the growing birth rate in countries like India, China, Pakistan, and Bangladesh, among others. The growing prevalence of hypertension, atherosclerosis, peripheral artery disease, heart failure, and thrombosis among the geriatric population in the region is likely to augment the market growth in the forecast period. The market is estimated to be further supplemented by the growing cases of breathing problems among the population, owing to the rising levels of air pollution worldwide.

Inhaled Nitric Oxide: Market Segmentation

Inhaled nitric oxide is defined as a selective pulmonary vasodilator, which regulates the muscle tone and treats hypoxemic respiratory failure among the newly born infants by improving ventilation-perfusion mismatch. It is used along with a breathing machine for the treatment of respiratory ailments such as COPD and ARDS.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on application, the market is segmented into:

• Neonatal Respiratory Treatment
• Chronic Obstructive Pulmonary Disease (COPD)
• Acute Respiratory Distress Syndrome (ARDS)
• Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Growing Use of the Product in the Healthcare Sector to Boost the Growth of the Inhaled Nitric Oxide Industry

The global inhaled nitric oxide industry is being driven by its growing application in the healthcare sector. The product has witnessed a significant surge in adoption by hospitals, ambulatory surgical centres, and advanced clinics, owing to the growing incidences of fatalities caused by respiratory ailments. The market is anticipated to be positively influenced by the changing patient preference towards minimally-invasive treatments and the growing healthcare expenditure in the emerging economies of the world. The market is estimated to be further supported by the growing cases of neonatal hypoxic respiratory failure. In addition, the rising air pollution levels worldwide are further leading to the growing incidences of respiratory diseases, especially among the geriatric population, which is estimated to support the market growth in the forecast period.

Key Industry Players in the Global Inhaled Nitric Oxide Market

The report gives a detailed analysis of the following key players in the global inhaled nitric oxide market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Bellerophon Therapeutics Inc.
• Air Liquide Group
• BOC Limited
• Vero Biotech, LLC
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report